Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994 (Q73411342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

P Remiszewski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Słodkowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Wiatr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Zych

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Radomski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Rowińska-Zakrzewska

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

101-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

Terminal pulmonary infections in patients with lung cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Pulmonary infections in lung cancer patients at diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

The impact of pulmonary infections on the survival of lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Treatment of small cell lung carcinoma in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Fungal infections in cancer patients: an international autopsy survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

Pulmonary complications in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900185-9

7 January 2021

10.1016/S0169-5002(00)00185-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165389%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference